Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer

被引：7

作者：

Huang, Audris ^{[1
]}

Jayaraman, Lata ^{[1
]}

Fura, Aberra ^{[1
]}

Vite, Gregory D. ^{[1
]}

Trainor, George L. ^{[1
]}

Gottardis, Marco M. ^{[1
]}

Spires, Thomas E. ^{[1
]}

Spires, Vanessa M. ^{[1
]}

Rizzo, Cheryl A. ^{[1
]}

Obermeier, Mary T. ^{[1
]}

Elzinga, Paul A. ^{[1
]}

Todderud, Gordon ^{[1
]}

Fan, Yi ^{[1
]}

Newitt, John A. ^{[1
]}

Beyer, Sophie M. ^{[1
]}

Zhu, Yongxin ^{[1
]}

Warrack, Bethanne M. ^{[1
]}

Goodenough, Angela K. ^{[1
]}

Tebben, Andrew J. ^{[1
]}

Doweyko, Arthur M. ^{[1
]}

Gold, David L. ^{[1
]}

Balog, Aaron ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Princeton, NJ 08543 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 01期

关键词：

Prostate cancer; CYP17A1; benzimidazoles; lyase; CYP11B1; CYP21A2; cortisol; CASTRATION-RESISTANT; 17,20-LYASE INHIBITOR; ORTERONEL TAK-700; N-ARYLATION; ABIRATERONE;

D O I：

10.1021/acsmedchemlett.5b00310

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Efforts to identify a potent, reversible, non steroidal CYP17A1 lyase inhibitor with good selectivity over CYP17A1 hydroxylase and CYPs 11B1 and 21A2 for the treatment of castration-resistant prostate cancer (CRPC) culminated in the discovery of BMS-351 (compound 18), a pyridyl biaryl benzimidazole with an excellent in vivo profile. Biological evaluation of BMS-351 at a dose of 1.5 mg in castrated cynomolgus monkeys revealed a remarkable reduction in testosterone levels with minimal glucocorticoid and mineralcorticoid perturbation. Based on a favorable profile, BMS-351 was selected as a candidate for further preclinical evaluation.

引用

页码：40 / 45

页数：6

共 50 条

[11] Mechanisms of resistance to CYP17A1 inhibitors in castrate resistant prostate cancer
Ripert, T.
Crouzet, S.
Ploussard, G.
De La Taille, A.
Robert, G.
PROGRES EN UROLOGIE, 2013, 23 : S16 - S22
[12] Activity of VT-464, a selective CYP17 lyase inhibitor, in the LNCaP prostate cancer xenograft model
Pisle, Stephen Todd
Pressler, Heather M.
Troutman, Sarah M.
Eisner, Joel Robert
Rafferty, Stephen W.
Schotzinger, Robert J.
Moore, William R.
Figg, William Douglas
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[13] Activity of oral VT-464, a selective CYP17-lyase inhibitor, in the LNCaP prostate cancer xenograft
Figg, William Douglas
Spencer, Shawn D.
Pisle, Stephen T.
Pressler, Heather M.
Troutman, Sarah M.
Eisner, Joel Robert
Rafferty, Stephen W.
Schotzinger, Robert J.
Moore, William R.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[14] ANTI-CANCER ACTIVITY OF THE SELECTIVE CYP17A1 INHIBITOR, VT-464, IN PRE-CLINICAL MODELS OF CASTRATE RESISTANT PROSTATE CANCER
Toren, Paul
Pham, Steven
Kim, Soojin
Adomat, Hans
Zoubeidi, Amina
Moore, William
Gleave, Martin
JOURNAL OF UROLOGY, 2014, 191 (04): : E808 - E808
[15] CYP17 lyase inhibitors as therapeutic agents for the treatment of prostate cancer
Huang, Audris
Balog, Aaron
Jayaraman, Lata
Frennesson, David
Saulnier, Mark
Velaparthi, Upender
Liu, Pei-Ying
Darne, Chetan
Vite, Gregory
Trainor, George
Gottardis, Marco
Spires, Thomas
Rodriguez, Vanessa
Rizzo, Cheryl
Obermeier, Mary
Elzinga, Paul
Todderud, Gordon
Fan, Yi
Newitt, John
Beyer, Sophie
Vyas, Dinesh
Fura, Aberra
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[16] HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
Almassi, Nima
Reichard, Chad
Li, Jianbo
Russell, Carly
Perry, Jaselle
Ryan, Charles J.
Friedlander, Terence
Sharifi, Nima
JAMA ONCOLOGY, 2018, 4 (04) : 554 - 557
[17] Targeting androgen production by posttranslational regulation of CYP17A1 lyase activity
Sharma, Katyayani
Pandey, Amit V.
HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 2): : 41 - 41
[18] The influence of steroid metabolism on CYP17A1 inhibitor activity
Claessens, Frank
Moris, Lisa
NATURE REVIEWS UROLOGY, 2017, 14 (10) : 590 - 591
[19] ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.
Kallio, Pekka
Oksala, Riikka
Moilanen, Anu
Riikonen, Reetta
Rummakko, Petteri
Malmstrom, Chira
Mustonen, Mika V. J.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[20] Targeting androgen production by posttranslational regulation of CYP17A1 lyase activity
Sharma, Katyayani
Pandey, Amit V.
HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 33 - 34

← 1 2 3 4 5 →